Company: ARTL
Filing Date: 2025-11-12
Form Type: 10-Q
Source: 0001640334-25-002022
Chunk: 85

Company: ARTELO BIOSCIENCES, INC.
Filing Date: 2025-11-12
Form: 10-Q
Item: Part II, Item 2
Chunk 85
---
 any filing of Artelo Biosciences, Inc. under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended, whether made before or after the date of this Quarterly Report on Form 10-Q, irrespective of any general incorporation language contained in such filing.

 35Table of Contents

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized. 

Artelo Biosciences, Inc.(Registrant)  Dated: November 12, 2025/s/ Gregory D. GorgasGregory D. GorgasPresident, Chief Executive Officer, and Director(Principal Executive Officer) 

     /s/ Mark Spring  Mark Spring   Chief Financial Officer and Treasurer   (Principal Financial Officer and   Principal Accounting Officer) 

 36